Zurcher Kantonalbank Zurich Cantonalbank Acquires 4,048 Shares of Crocs, Inc. (NASDAQ:CROX)

Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Crocs, Inc. (NASDAQ:CROXFree Report) by 34.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,706 shares of the textile maker’s stock after acquiring an additional 4,048 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Crocs were worth $2,292,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. V Square Quantitative Management LLC bought a new stake in shares of Crocs during the first quarter valued at approximately $25,000. Rise Advisors LLC purchased a new position in Crocs in the 1st quarter worth approximately $25,000. Quest Partners LLC bought a new position in Crocs in the 4th quarter valued at approximately $53,000. Manchester Capital Management LLC lifted its holdings in shares of Crocs by 1,673.5% during the fourth quarter. Manchester Capital Management LLC now owns 603 shares of the textile maker’s stock valued at $56,000 after purchasing an additional 569 shares in the last quarter. Finally, Blue Trust Inc. boosted its position in shares of Crocs by 19.3% during the second quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock valued at $144,000 after buying an additional 162 shares during the last quarter. Hedge funds and other institutional investors own 93.44% of the company’s stock.

Insider Buying and Selling

In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the sale, the director now directly owns 81,254 shares of the company’s stock, valued at approximately $10,756,404.52. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Douglas J. Treff sold 10,594 shares of the company’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the transaction, the director now owns 81,254 shares in the company, valued at $10,756,404.52. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Andrew Rees sold 10,000 shares of Crocs stock in a transaction on Monday, June 17th. The shares were sold at an average price of $160.15, for a total transaction of $1,601,500.00. Following the completion of the sale, the chief executive officer now owns 79,748 shares in the company, valued at $12,771,642.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 27,744 shares of company stock valued at $4,140,855. Corporate insiders own 2.72% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Williams Trading upgraded shares of Crocs from a “hold” rating to a “buy” rating and upped their target price for the company from $135.00 to $163.00 in a research note on Thursday, August 22nd. UBS Group cut their price objective on Crocs from $148.00 to $146.00 and set a “neutral” rating for the company in a report on Tuesday, July 16th. Monness Crespi & Hardt increased their target price on Crocs from $140.00 to $170.00 and gave the company a “buy” rating in a report on Wednesday, May 8th. Piper Sandler reissued an “overweight” rating and issued a $170.00 target price on shares of Crocs in a research report on Friday, August 23rd. Finally, StockNews.com raised shares of Crocs from a “hold” rating to a “buy” rating in a research report on Friday, August 23rd. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $160.27.

Read Our Latest Research Report on CROX

Crocs Stock Performance

Shares of NASDAQ CROX opened at $146.17 on Friday. The stock has a market cap of $8.87 billion, a PE ratio of 11.31, a price-to-earnings-growth ratio of 1.45 and a beta of 2.00. Crocs, Inc. has a 1 year low of $74.00 and a 1 year high of $165.32. The firm has a fifty day moving average price of $137.79 and a 200-day moving average price of $136.24. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.50 and a quick ratio of 1.14.

Crocs (NASDAQ:CROXGet Free Report) last posted its quarterly earnings results on Thursday, August 1st. The textile maker reported $4.01 EPS for the quarter, beating analysts’ consensus estimates of $3.59 by $0.42. Crocs had a return on equity of 53.20% and a net margin of 20.02%. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the firm earned $3.59 earnings per share. The business’s quarterly revenue was up 3.6% on a year-over-year basis. Equities analysts anticipate that Crocs, Inc. will post 12.73 earnings per share for the current fiscal year.

Crocs Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

See Also

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.